As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Medicilon offers comprehensive and FDA/CFDA GLP-compliant bioanalysis services to support preclinical and clinical development for small molecule drugs, biologics, vaccines and biomarkers.
– Inflammation Markers
– Tumor Markers
– Metabolic Markers
– Cardiovascular Markers
– Bone Markers
Biomarkers are rapidly becoming the main drivers of innovation for medicine in the 21st century. Biomarkers are used as indicators of biological processes and pharmacological responses to a specific drug or therapy.
Since they improve the potential to tailor treatment to the specific needs of individual patients, they have become a critical prerequisite to personalized medicine, companion diagnostics and they are also an integral part of the drug discovery and development process.
Medicilon provides comprehensive laboratory support for all stages of product development, from early discovery and preclinical studies (non-GLP and GLP). Our dedicated and highly experienced scientists use state-of-the-art technologies for biomarker analysis to support preclinical projects where fast data turn-around may be of essence.
Biomarker & Assay Development Services are available as package or single services:
1. Biomarker Discovery
Identification of new disease-specific metabolite panels in exploratory studies including experimental design, application of statistical models, biochemical interpretation and pathway mapping
2. Assay Development (Development and Application of Biomarker Assays)
Development of quantitative mass spectrometry based biomarker assays, validation (fit-for-purpose) and documentation3. Biomarker Testing
Verification of metabolomic biomarkers in independent sample cohorts
4. Bioinformatics & Customized Output
Statistical analysis, biochemical data interpretation, customized data reports, decision support and study design
All Biomarker Testing Service personnel training is reviewed and documented annually:
– Quality Manual Review
– Safety Training
– Assay Training
– SOP Training
Email : marketing@medicilon.com
Tel : +86 021 58591500
Tips: Above is part of biomarker assay, biomarker analysis, biomarker discovery and development. You can also CONTACT US with any question or enquiry you may have. We will be happy to discuss your needs in detail and design an appropriate plan of action.